GGrantIndex
← Leaderboards

Sarah Leasure Reeves

University Of Michigan At Ann Arbor

$2,261,285
Attributed
$2,261,285
Total exposure
2
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $450.6K · FY201624
$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

AHRQ$1,634,841 · 1
NIH$626,444 · 1

By mechanism

R01$1,634,841 · 1
K01$626,444 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Diagnosis

Research focus

DiagnosisAdolescentAdverse OutcomeAcute Chest SyndromeAfrican AmericanAge-MonthsApplications GrantsBaseAffectAdherenceCareer DevelopmentCaregiversCharacteristicsChildChronicChronic DepressionChronic PainCommon SymptomComparative EffectivenessBirthComplementCareerDecision MakingDisease Management

Grant awards (10)

Opportunities to optimize the receipt of preventive services among children with sickle cell anemia: A Mixed Methods Approach$366,870
R01 · FY2024 · HS · contact PI
Opportunities to optimize the receipt of preventive services among children with sickle cell anemia: A Mixed Methods Approach$83,736
R01 · FY2024 · HS · contact PI
Opportunities to optimize the receipt of preventive services among children with sickle cell anemia: A Mixed Methods Approach$400,000
R01 · FY2023 · HS · contact PI
Opportunities to optimize the receipt of preventive services among children with sickle cell anemia: A Mixed Methods Approach$388,241
R01 · FY2022 · HS · contact PI
Opportunities to optimize the receipt of preventive services among children with sickle cell anemia: A Mixed Methods Approach$395,994
R01 · FY2021 · HS · contact PI
Identifying Opportunities to Improve Hydroxyurea Therapy Initiation and Adherence among Children with Sickle Cell Disease$130,860
K01 · FY2020 · HL · contact PI
Identifying Opportunities to Improve Hydroxyurea Therapy Initiation and Adherence among Children with Sickle Cell Disease$127,992
K01 · FY2019 · HL · contact PI
Identifying Opportunities to Improve Hydroxyurea Therapy Initiation and Adherence among Children with Sickle Cell Disease$125,208
K01 · FY2018 · HL · contact PI
Identifying Opportunities to Improve Hydroxyurea Therapy Initiation and Adherence among Children with Sickle Cell Disease$122,504
K01 · FY2017 · HL · contact PI
Identifying Opportunities to Improve Hydroxyurea Therapy Initiation and Adherence among Children with Sickle Cell Disease$119,880
K01 · FY2016 · HL · contact PI